AR and colorectal carcinoma: In more detail, we suggest that the use of ovarian sex steroid hormones (33–36, 50, 51), as well as blocking androgen receptor (38–40), could inhibit CRC progression by modulating the regulatory molecules of cell cycle and apoptosis.